Adirondack Trust CO Gilead Sciences, Inc. Transaction History

Adirondack Trust CO

$259 Million
Q3 2024

A detailed history of Adirondack Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Adirondack Trust CO holds 1,928 shares of GILD stock, worth $170,550. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,928

Previous 2,130 9.48%

Holding current value

$170,550

Previous $146,000 10.27%

% of portfolio

0.06%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$66.59 - $83.99 $13,451 - $16,965	-202 Reduced 9.48%	1,928 $161,000
Q4 2023 Mar 29, 2024	SELL	$73.27 - $83.09 $7,327 - $8,309	-100 Reduced 4.48%	2,130 $172,000
Q3 2023 Oct 31, 2023	SELL	$73.94 - $80.67 $31,424 - $34,284	-425 Reduced 16.01%	2,230 $167,000
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $2,280 - $2,601	-30 Reduced 1.12%	2,655 $204,000
Q3 2022 Oct 13, 2022	SELL	$59.54 - $68.01 $26,793 - $30,604	-450 Reduced 14.35%	2,685 $166,000
Q2 2022 Jul 06, 2022	BUY	$57.72 - $65.01 $24,531 - $27,629	425 Added 15.68%	3,135 $193,000
Q1 2022 Apr 05, 2022	BUY	$57.92 - $72.58 $10,136 - $12,701	175 Added 6.9%	2,710 $161,000
Q4 2021 Jan 13, 2022	SELL	$64.88 - $73.64 $17,842 - $20,251	-275 Reduced 9.79%	2,535 $184,000
Q2 2021 Jul 15, 2021	SELL	$63.47 - $69.35 $2,538 - $2,774	-40 Reduced 1.4%	2,810 $193,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $2,266 - $2,582	40 Added 1.42%	2,850 $187,000
Q1 2020 Apr 23, 2020	SELL	$62.63 - $80.22 $10,020 - $12,835	-160 Reduced 5.39%	2,810 $210,000
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $17,561 - $19,317	-285 Reduced 8.76%	2,970 $187,000
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $19,822 - $22,205	-317 Reduced 8.87%	3,255 $212,000
Q4 2018 Jan 18, 2019	SELL	$60.54 - $79.0 $49,824 - $65,017	-823 Reduced 18.73%	3,572 $223,000
Q3 2018 Oct 22, 2018	SELL	$71.28 - $78.92 $56,667 - $62,741	-795 Reduced 15.32%	4,395 $340,000
Q2 2018 Jul 26, 2018	SELL	$64.88 - $75.68 $70,459 - $82,188	-1,086 Reduced 17.3%	5,190 $368,000
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $54,265 - $66,156	-745 Reduced 10.61%	6,276 $453,000
Q4 2017 Jan 10, 2018	SELL	$71.15 - $83.52 $12,095 - $14,198	-170 Reduced 2.36%	7,021 $503,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $518,543 - $614,614	7,191	7,191 $582,000

Others Institutions Holding GILD

# of Institutions

1,925

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.

Account

Adirondack Trust CO Gilead Sciences, Inc. Transaction History